Drug Repurposing
A research strategy that applies drugs already approved for clinical use or having completed partial clinical trials to treat diseases beyond their original indications. By leveraging accumulated safety data from prior development, this approach can compress development timelines and reduce costs compared to de novo drug discovery.
Timeline (last 90 days)
The Project Quine team applied the system to drug repurposing research for pancreatic cancer, searching for potential efficacy among already-approved known compounds.
Drug repurposing refers to applying drugs that have already been approved for market or have completed part of clinical trials to treat diseases beyond their original indications, which can significantly compress the preclinical research timeline and reduce R&D costs.
Traditional drug repurposing relies on manual literature curation or limited-scale cell line screening, whereas the introduction of computational models makes it possible to rapidly complete preliminary screening at full-library scale.
All Facts (3)
Drug repurposing refers to applying drugs that have already been approved for market or have completed part of clinical trials to treat diseases beyond their original indications, which can significantly compress the preclinical research timeline and reduce R&D costs.
50%UnverifiedTraditional drug repurposing relies on manual literature curation or limited-scale cell line screening, whereas the introduction of computational models makes it possible to rapidly complete preliminary screening at full-library scale.
50%UnverifiedThe Project Quine team applied the system to drug repurposing research for pancreatic cancer, searching for potential efficacy among already-approved known compounds.
50%